“GLP-2” and “GLP-3”, decoded
There is no hormone called GLP-3. The nicknames count how many body signals a medicine copies.
Transcript and sources
- There's no hormone called GLP-3. So what is everyone talking about?
- Those names are counting something real: the body signals a medicine copies. Learn to count them, and the whole family makes sense.
- Start with the real one. GLP-1 is a hormone your gut sends after a meal. It helps release insulin when blood sugar is high, and tells your brain you've had enough.
- Most of these medicines copy only GLP-1: semaglutide, in Ozempic and Wegovy; liraglutide; dulaglutide; and a new pill, orforglipron.
- Tirzepatide, in Mounjaro and Zepbound, copies two signals: GLP-1 and GIP. Online, that earns it the nickname GLP-2. But the real GLP-2 is a different hormone, one that helps the gut lining grow.
- Retatrutide copies three: GLP-1, GIP, and glucagon. That's the GLP-3. Its maker calls the name inaccurate, and it's still in trials, not approved.
- So skip the numbers and count the signals: GLP-1 alone, plus GIP, plus glucagon, or plus amylin, a fullness signal from the pancreas.
- And if someone sells a GLP-3 labelled for research, it is not approved medicine. The FDA has sent warning letters to sellers using these names.
- Every medicine, and the evidence behind it, is at peplexicon.com.
Sources
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007
- Ozempic (semaglutide) prescribing information, DailyMed
- Wegovy (semaglutide) injection and tablets prescribing information, DailyMed
- Foundayo (orforglipron) prescribing information, DailyMed
- Mounjaro (tirzepatide) prescribing information, DailyMed
- Zepbound (tirzepatide) prescribing information, DailyMed
- Gattex (teduglutide) prescribing information, DailyMed
- Eli Lilly: What to know about retatrutide
- Eli Lilly: retatrutide TRIUMPH-1 phase 3 topline results, May 21, 2026 (not yet peer reviewed)
- FDA warning letter to Gram Peptides (tirzepatide sold as “GLP-2 peptide”), Mar 31, 2026
- FDA warning letter to Mile High Compounds (“GLP-2 TRZ”, “GLP-3 RT”), Mar 31, 2026